Jason B. Daly sold $792K of Amneal Pharmaceuticals (AMRX)

Executed Mar 5 2025, disclosed Mar 7 2025, 2 days later.

Value, as filed

$792K

90,000 sh across 2 lots

Executed

Mar 5 2025

the trade date, as filed

Disclosed

Mar 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JD Jason B. Daly SVP, Chief Legal Officer profile →

Jason B. Daly (SVP, Chief Legal Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $3.8M of AMRX (216,613 sh across 2 lots, as filed), executed Aug 11.

The name

AMRX Amneal Pharmaceuticals, Inc. AMRX · Healthcare · 32 filings in 24 months ticker →

Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jason B. Daly in AMRX

AMRXSALE Amneal Pharmaceuticals, Inc. $3.8M
216,613 sh across 2 lots
Exec Aug 11
Filed Aug 13 · 4:21 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $199K
22,000 sh × $9.05
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $115K
13,665 sh × $8.40
Exec Nov 21 2024
Filed Nov 22 2024 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $376K
43,657 sh × $8.61
Exec Nov 15 2024
Filed Nov 19 2024 · 5:30 PM ET